The flushing patient: Differential diagnosis, workup, and treatment

Journal of the American Academy of Dermatology

Volumn 55, Issue 2, 2006, Pages 193-208

  Izikson, Leonid ^a   English III, Joseph C ^a   Zirwas, Matthew J ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIBIOTIC AGENT; ANTIPYRETIC AGENT; AZELAIC ACID; BENZOYL PEROXIDE; CHLORPROMAZINE; CLINDAMYCIN; CLONIDINE; DERMATOLOGICAL AGENT; ERYTHROMYCIN; ISOTRETINOIN; KETANSERIN; MACROLIDE; METRONIDAZOLE; NADOLOL; NALOXONE; NONSTEROID ANTIINFLAMMATORY AGENT; OCTREOTIDE; ORAL CONTRACEPTIVE AGENT; PARACETAMOL; PROPRANOLOL; RETINOIC ACID; SEROTONIN ANTAGONIST; SPIRONOLACTONE; SULFANILAMIDE DERIVATIVE; TACROLIMUS; TETRACYCLINE DERIVATIVE; TRIAMCINOLONE; UNINDEXED DRUG; VANCOMYCIN;

ANAMNESIS; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; BEHAVIOR THERAPY; BENIGN CUTANEOUS FLUSHING; CARCINOID SYNDROME; CLINICAL FEATURE; COGNITIVE DEFECT; DIAGNOSTIC ACCURACY; DIARRHEA; DIFFERENTIAL DIAGNOSIS; DISEASE EXACERBATION; DIZZINESS; DRUG FATALITY; DYSPNEA; EMOTION; EMOTIONAL FLUSHING; ERYTHEMATOTELANGIECTATIC ROSACEA; FEEDBACK SYSTEM; FEVER; FOOD INTAKE; FOOD POISONING; FREY SYNDROME; HISTOPATHOLOGY; HOT FLUSH; HUMAN; HYPERTENSION; HYPERTHERMIA; HYPNOSIS; HYPOGLYCEMIA; HYPOTENSION; KIDNEY CARCINOMA; LABORATORY DIAGNOSIS; LOW LEVEL LASER THERAPY; MASTOCYTOSIS; MENOPAUSAL SYNDROME; NAUSEA AND VOMITING; NEUROLOGIC DISEASE; NIGHT SWEAT; PANCREAS TUMOR; PHEOCHROMOCYTOMA; PHOTOTHERAPY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RADIODIAGNOSIS; REVIEW; ROSACEA; SKIN BLOOD FLOW; SYNCOPE; THYROID MEDULLARY CARCINOMA; TOPICAL TREATMENT; TREATMENT OUTCOME; URTICARIA; WHEEZING;

ALCOHOL DRINKING; DIAGNOSIS, DIFFERENTIAL; DRUG ERUPTIONS; FLUSHING; HUMANS; MENOPAUSE; MENTAL DISORDERS; NEOPLASMS; NERVOUS SYSTEM DISEASES; ROSACEA;

EID: 33745845164     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2005.07.057     Document Type: Review

References (101)

1. Mohyi D., Tabassi K., and Simon J. Differential diagnosis of hot flashes. Maturitas 27 (1997) 203-214
2. Metcalfe D.D. Differential diagnosis of the patient with unexplained flushing/anaphylaxis. Allergy Asthma Proc 21 (2000) 21-24
3. Friedman B.S., Germano P., Miletti J., and Metcalfe D.D. A clinicopathologic study of ten patients with recurrent unexplained flushing. J Allergy Clin Immunol 93 part 1 (1994) 53-60
4. Ray D., and Williams G. Pathophysiological causes and clinical significance of flushing. Br J Hosp Med 50 (1993) 594-598
5. Aldrich L.B., Moattari A.R., and Vinik A.I. Distinguishing features of idiopathic flushing and carcinoid syndrome. Arch Intern Med 148 (1988) 2614-2618
6. Mooney E. The flushing patient. Int J Dermatol 24 (1985) 549-554
7. Wilkin J.K. Flushing reactions in the cancer chemotherapy patient. The lists are longer but the strategies are the same. Arch Dermatol 128 (1992) 1387-1389
8. Wilkin J.K. The red face: flushing disorders. Clin Dermatol 11 (1993) 211-223
9. Wilkin J.K. Why is flushing limited to a mostly facial cutaneous distribution?. J Am Acad Dermatol 19 (1988) 309-313
10. Wilkin J.K. Flushing reactions: consequences and mechanisms. Ann Intern Med 95 (1981) 468-476
11. Mourad O., Palda V., and Detsky A.S. A comprehensive evidence-based approach to fever of unknown origin. Arch Intern Med 163 (2003) 545-551
12. Settipane G.A. The restaurant syndromes. N Engl Reg Allergy Proc 8 (1987) 39-46
13. Malone M.H., and Metcalfe D.D. Histamine in foods: its possible role in non-allergic adverse reactions to ingestants. N Engl Reg Allergy Proc 7 (1986) 241-245
14. Becker K., Southwick K., Reardon J., Berg R., and MacCormack J.N. Histamine poisoning associated with eating tuna burgers. JAMA 285 (2001) 1327-1330
15. Attaran R.R., and Probst F. Histamine fish poisoning: a common but frequently misdiagnosed condition. Emerg Med J 19 (2002) 474-475
16. Smart D.R. Scombroid poisoning. A report of seven cases involving the Western Australian salmon, Arripis truttaceus. Med J Aust 157 (1992) 748-751
17. Morrow J.D., Margolies G.R., Rowland J., and Roberts II L.J. Evidence that histamine is the causative toxin of scombroid-fish poisoning. N Engl J Med 324 (1991) 716-720
18. Crawford G.H., Pelle M.T., and James W.D. Rosacea: I. Etiology, pathogenesis, and subtype classification. J Am Acad Dermatol 51 (2004) 327-341
19. Pelle M.T., Crawford G.H., and James W.D. Rosacea: II. Therapy. J Am Acad Dermatol 51 (2004) 499-512
20. Bider D., Mashiach S., Serr D.M., and Ben-Rafael Z. Endocrinological basis of hot flushes. Obstet Gynecol Surv 44 (1989) 495-499
21. Rebar R.W., and Spitzer I.B. Endocrinological basis of hot flushes. Obstet Gynecol Surv 44 (1989) 495-499
22. Hersh A.L., Stefanick M.L., and Stafford R.S. National use of postmenopausal hormone therapy: annual trends and response to recent evidence. JAMA 291 (2004) 47-53
23. Cushman M., Kuller L.H., Prentice R., Rodabough R.J., Psaty B.M., Stafford R.S., et al. Estrogen plus progestin and risk of venous thrombosis. JAMA 292 (2004) 1573-1580
24. Rossouw J.E., Anderson G.L., Prentice R.L., LaCroix A.Z., Kooperberg C., Stefanick M.L., et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 288 (2002) 321-333
25. Lucero M.A., and McCloskey W.W. Alternatives to estrogen for the treatment of hot flashes. Ann Pharmacother 31 (1997) 915-917
26. Lightman S.L., Jacobs H.S., Maguire A.K., McGarrick G., and Jeffcoate S.L. Climacteric flushing: clinical and endocrine response to infusion of naloxone. Br J Obstet Gynaecol 88 (1981) 919-924
27. Kulke M.H., and Mayer R.J. Carcinoid tumors. N Engl J Med 340 (1999) 858-868
28. Ganim R.B., and Norton J.A. Recent advances in carcinoid pathogenesis, diagnosis and management. Surg Oncol 9 (2000) 173-179
29. Crocetti E., and Paci E. Malignant carcinoids in the USA, SEER 1992-1999. An epidemiological study with 6830 cases. Eur J Cancer Prev 12 (2003) 191-194
30. Taupenot L., Harper K.L., and O'Connor D.T. The chromogranin-secretogranin family. N Engl J Med 348 (2003) 1134-1149
31. Metz S.A., Halter J.B., Porte Jr. D., and Robertson R.P. Suppression of plasma catecholamines and flushing by clonidine in man. J Clin Endocrinol Metab 46 (1978) 83-90
32. McGuinness M.E., and Talbert R.L. Pharmacologic stress testing: experience with dipyridamole, adenosine, and dobutamine. Am J Hosp Pharm 51 (1994) 328-346
33. Richer M., Robert S., and Lebel M. Renal hemodynamics during norepinephrine and low-dose dopamine infusions in man. Crit Care Med 24 (1996) 1150-1156
34. Reid J.L., Wing L.M., Dargie H.J., Hamilton C.A., Davies D.S., and Dollery C.T. Clonidine withdrawal in hypertension. Changes in blood-pressure and plasma and urinary noradrenaline. Lancet 1 (1977) 1171-1174
35. Campbell B.C., Elliott H.L., Hamilton C.A., and Reid J.L. Changes in blood pressure, heart rate, and sympathetic activity on abrupt withdrawal of tiamenidine (HOE 440) in essential hypertension. Eur J Clin Pharmacol 18 (1980) 449-454
36. Saito H. Congenital Horner's syndrome with unilateral facial flushing. J Neurol Neurosurg Psychiatry 53 (1990) 85-86
37. Herrera M.F., Stone E., Deitel M., and Asa S.L. Pheochromocytoma producing multiple vasoactive peptides. Arch Surg 127 (1992) 105-108
38. Smith S.L., Slappy A.L., Fox T.P., and Scolapio J.S. Pheochromocytoma producing vasoactive intestinal peptide. Mayo Clin Proc 77 (2002) 97-100
39. Kitamura K., Kangawa K., Kawamoto M., Ichiki Y., Matsuo H., and Eto T. Isolation and characterization of peptides which act on rat platelets, from a pheochromocytoma. Biochem Biophys Res Commun 185 (1992) 134-141
40. Mouri T., Takahashi K., Sone M., Murakami O., Ohneda M., Itoi K., et al. Calcitonin gene-related peptide-like immunoreactivities in pheochromocytomas. Peptides 10 (1989) 201-204
41. Letizia C., Rossi G., and Cerci S. Adrenomedullin and endocrine disorders. Panminerva Med 45 (2003) 241-251
42. Nicholls M.G., Lainchbury J.G., Lewis L.K., McGregor D.O., Richards A.M., Troughton R.W., et al. Bioactivity of adrenomedullin and proadrenomedullin N-terminal 20 peptide in man. Peptides 22 (2001) 1745-1752
43. Pacak K., Linehan W.M., Eisenhofer G., Walther M.M., and Goldstein D.S. Recent advances in genetics, diagnosis, localization, and treatment of pheochromocytoma. Ann Intern Med 134 (2001) 315-329
44. Lenders J.W., Pacak K., and Eisenhofer G. New advances in the biochemical diagnosis of pheochromocytoma: moving beyond catecholamines. Ann N Y Acad Sci 970 (2002) 29-40
45. Valent P., Akin C., Sperr W.R., Horny H.P., Arock M., Lechner K., et al. Diagnosis and treatment of systemic mastocytosis: state of the art. Br J Haematol 122 (2003) 695-717
46. Escribano L., Akin C., Castells M., Orfao A., and Metcalfe D.D. Mastocytosis: current concepts in diagnosis and treatment. Ann Hematol 81 (2002) 677-690
47. Tharp M.D. Mastocytosis. In: Bolognia J.L., et al. (Ed). Dermatology (2003), Mosby, New York (NY) 1899-1906
48. Tharp M.D., and Longley Jr. B.J. Mastocytosis. Dermatol Clin 19 (2001) 679-696
49. Sawalha A.H., Bronze M.S., Saint S., Blevins S., and Kern W. Clinical problem-solving. Step by step. N Engl J Med 349 (2003) 2253-2257
50. Feger F., Ribadeau Dumas A., Leriche L., Valent P., and Arock M. Kit and c-kit mutations in mastocytosis: a short overview with special reference to novel molecular and diagnostic concepts. Int Arch Allergy Immunol 127 (2002) 110-114
51. Longley Jr. B.J., Metcalfe D.D., Tharp M., Wang X., Tyrrell L., Lu S.Z., et al. Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis. Proc Natl Acad Sci U S A 96 (1999) 1609-1614
52. Pardanani A., Elliott M., Reeder T., Li C.Y., Baxter E.J., Cross N.C., et al. Imatinib for systemic mast-cell disease. Lancet 362 (2003) 535-536
53. Kemp S.F., and Lockey R.F. Anaphylaxis: a review of causes and mechanisms. J Allergy Clin Immunol 110 (2002) 341-348
54. Wells Jr. S.A., and Franz C. Medullary carcinoma of the thyroid gland. World J Surg 24 (2000) 952-956
55. Krejs G.J. VIPoma syndrome. Am J Med 82 (1987) 37-48
56. Mansour J.C., and Chen H. Pancreatic endocrine tumors. J Surg Res 120 (2004) 139-161
57. Plaksin J., Landau Z., and Coslovsky R. A carcinoid-like syndrome caused by a prostaglandin-secreting renal cell carcinoma. Arch Intern Med 140 (1980) 1095-1096
58. Papac R.J., and Poo-Hwu W.J. Renal cell carcinoma: a paradigm of lanthanic disease. Am J Clin Oncol 22 (1999) 223-231
59. Hickey K.J., Vogel L.C., Willis K.M., and Anderson C.J. Prevalence and etiology of autonomic dysreflexia in children with spinal cord injuries. J Spinal Cord Med 27 Suppl 1 (2004) S54-S60
60. Finestone H.M., and Teasell R.W. Autonomic dysreflexia after brainstem tumor resection. A case report. Am J Phys Med Rehabil 72 (1993) 395-397
61. Colachis III S.C. Autonomic hyperreflexia with spinal cord injury. J Am Paraplegia Soc 15 (1992) 171-186
62. Vaidyanathan S., Soni B.M., Sett P., Watt J.W., Oo T., and Bingley J. Pathophysiology of autonomic dysreflexia: long-term treatment with terazosin in adult and paediatric spinal cord injury patients manifesting recurrent dysreflexic episodes. Spinal Cord 36 (1998) 761-770
63. McGregor J.A., and Meeuwsen J. Autonomic hyperreflexia: a mortal danger for spinal cord-damaged women in labor. Am J Obstet Gynecol 151 (1985) 330-333
64. Metz S.A., Halter J.B., Porte Jr. D., and Robertson R.P. Autonomic epilepsy: clonidine blockade of paroxysmal catecholamine release and flushing. Ann Intern Med 88 (1978) 189-193
65. Wakai S., Asanuma H., Hayasaka H., Kawamoto Y., Sueoka H., Ishikawa Y., et al. Ictal video-EEG analysis of infantile neuroaxonal dystrophy. Epilepsia 35 (1994) 823-826
66. Baumgartner C., Lurger S., and Leutmezer F. Autonomic symptoms during epileptic seizures. Epileptic Disord 3 (2001) 103-116
67. Sakakibara R., Mori M., Fukutake T., Kita K., and Hattori T. Orthostatic hypotension in a case with multiple sclerosis. Clin Auton Res 7 (1997) 163-165
68. Mitsui T., Kawai H., Taguchi E., Miyamoto H., and Saito S. Autonomic hyperreflexia in pure progressive autonomic failure: a case report. Neurology 43 (1993) 1823-1825
69. Hillen M.E., and Sage J.I. Nonmotor fluctuations in patients with Parkinson's disease. Neurology 47 (1996) 1180-1183
70. Morrison D.A., Bibby K., and Woodruff G. The "harlequin" sign and congenital Horner's syndrome. J Neurol Neurosurg Psychiatry 62 (1997) 626-628
71. Lance J.W., Drummond P.D., Gandevia S.C., and Morris J.G. Harlequin syndrome: the sudden onset of unilateral flushing and sweating. J Neurol Neurosurg Psychiatry 51 (1988) 635-642
72. Dizon M.V., Fischer G., Jopp-McKay A., Treadwell P.W., and Paller A.S. Localized facial flushing in infancy. Auriculotemporal nerve (Frey) syndrome. Arch Dermatol 133 (1997) 1143-1145
73. Davis R.S., and Strunk R.C. Auriculotemporal syndrome in childhood. Am J Dis Child 135 (1981) 832-833
74. Kaddu S., Smolle J., Komericki P., and Kerl H. Auriculotemporal (Frey) syndrome in late childhood: an unusual variant presenting as gustatory flushing mimicking food allergy. Pediatr Dermatol 17 (2000) 126-128
75. Curran C.F. Doxorubicin-associated facial flushing. Arch Dermatol 128 (1992) 1408
76. Pontiroli A.E., De Pasqua A., Colombo R., Ricordi C., and Pozza G. Characterization of the chlorpropamide-alcohol-flush in patients with type 1 and type 2 diabetes. Acta Diabetol Lat 20 (1983) 117-123
77. Fitzsimons T.J. Calcium antagonists: a review of the recent comparative trials. J Hypertens Suppl 5 (1987) S11-S15
78. Brown M.J., and Morice A.H. Clinical pharmacology of vasodilator peptides. J Cardiovasc Pharmacol 10 Suppl 12 (1987) S82-S87
79. Capurso A. Drugs affecting triglycerides. Cardiology 78 (1991) 218-225
80. Smith E.R., and Mason M.M. Toxicology of the prostaglandins. Prostaglandins 7 (1974) 247-268
81. Sticherling M., and Brasch J. Alcohol: intolerance syndromes, urticarial and anaphylactoid reactions. Clin Dermatol 17 (1999) 417-422
82. Litt, and Jerome Z. Drug eruption reference manual. 11th edition (2005), Taylor & Francis Group, New York (NY)
83. Thomasson H.R., Crabb D.W., Edenberg H.J., and Li T.K. Alcohol and aldehyde dehydrogenase polymorphisms and alcoholism. Behav Genet 23 (1993) 131-136
84. Eriksson C.J. The role of acetaldehyde in the actions of alcohol (update 2000). Alcohol Clin Exp Res 25 suppl (2001) 15S-32S
85. Harrower A.D. Comparative tolerability of sulphonylureas in diabetes mellitus. Drug Saf 22 (2000) 313-320
86. Bussell K.L., Murphy F.Y., Nicks S.A., and Vesely D.L. Facial flushing secondary to hypoglycemia. J Med 18 (1987) 123-132
87. Milingou M., Antille C., Sorg O., Saurat J.H., and Lubbe J. Alcohol intolerance and facial flushing in patients treated with topical tacrolimus. Arch Dermatol 140 (2004) 1542-1544
88. Lubbe J., and Milingou M. Images in clinical medicine. Tacrolimus ointment, alcohol, and facial flushing. N Engl J Med 351 (2004) 2740
89. Ehst B.D., and Warshaw E.M. Alcohol-induced application site erythema after topical immunomodulator use and its inhibition by aspirin. Arch Dermatol 140 (2004) 1014-1015
90. Sirinek K.R., O'Dorisio T.M., Howe B., and McFee A.S. Neurotensin, vasoactive intestinal peptide, and Roux-en-Y gastrojejunostomy. Their role in the dumping syndrome. Arch Surg 120 (1985) 605-609
91. McReynolds S.M., Freidberg S.R., Guay A.T., Lee A.K., Pazianos A.G., and Hussain S.F. Hot flushes in men with pituitary adenoma. Surg Neurol 44 (1995) 14-17
92. Nicholls D.P., and Anderson D.C. Clinical aspects of androgen deficiency in men. Andrologia 14 (1982) 379-388
93. Uede K., and Furukawa F. Skin manifestations in acute arsenic poisoning from the Wakayama curry-poisoning incident. Br J Dermatol 149 (2003) 757-762
94. Myers B.M., Miralles G.D., Taylor C.A., Gastineau D.A., Pisani R.J., and Talley N.J. POEMS syndrome with idiopathic flushing mimicking carcinoid syndrome. Am J Med 90 (1991) 646-648
95. Rosenthal S., Schwartz J.H., and Canellos G.P. Basophilic chronic granulocytic leukaemia with hyperhistaminaemia. Br J Haematol 36 (1977) 367-372
96. Tkezawa H., Hayashi H., and Matsukage H. Edema (of the face and extremities), flushing and sense of fatigue of the extremities (hypokalemia, osteoporosis and hypertension): bronchial carcinoid (ACTH-producing tumor). Nippon Rinsho 866-7 (1975) 1298-1299
97. Singer W., Kovacs K., Ryan N., and Horvath E. Ectopic ACTH syndrome: clinicopathological correlations. J Clin Pathol 31 (1978) 591-598
98. Seltzer J.L., Goldberg M.E., Larijani G.E., Ritter D.E., Starsnic M.A., Stahl G.L., et al. Prostacyclin mediation of vasodilation following mesenteric traction. Anesthesiology 68 (1988) 514-518
99. Blanchet P. Paroxystic vasomotor skin manifestations. Ann Dermatol Venereol 105 (1978) 1001-1007
100. Niepomniszcze H., and Amad R.H. Skin disorders and thyroid diseases. J Endocrinol Invest 24 (2001) 628-638
101. Fava M. Depression with anger attacks. J Clin Psychiatry 59 Suppl 18 (1998) 18-22